Kaminga Atipatsa Chiwanda, Dai Wenjie, Liu Aizhong, Myaba Japhet, Banda Richard, Wen Shi Wu, Pan Xiongfeng
Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Department of Mathematics and Statistics, Mzuzu University, Private Bag 201, Luwinga.
Medicine (Baltimore). 2018 Nov;97(45):e13078. doi: 10.1097/MD.0000000000013078.
Although longer duration of untreated psychosis (DUP) is associated with poor response to antipsychotic treatment, it remains unclear whether it independently influences time to symptomatic remission in first-episode psychosis (FEP). This study examined rate of symptomatic remission, and explored if DUP, premorbid functioning, global functioning, insight and socio-demographic characteristics were independently associated with time to symptomatic remission in FEP.This prospective study enrolled 126 FEP patients (aged 18-65) between June 2009 and September 2012. Subjects were followed-up monthly over 18 months after they had received antipsychotic medication. Remission in positive and negative symptoms was defined as in the Remission in Schizophrenia Working Group (RSWG) criteria. Subjects were defined as "in symptomatic remission" if they remitted in both negative and positive symptoms. At baseline, the following explanatory variables were measured: socio-demographic characteristics; DUP as short (≤5 months) and long (>5 months); premorbid functioning as deteriorating, stable poor, and stable good according to Cannon-Spoor Premorbid Adjustment Scale; global functioning as "worst (1-10) to serious (41-50)" and "moderate (51-60) to superior (91-100)," according to the Global Assessment of Functioning Scale; and insight as poor (≤8) and good (≥9) according to the Insight Scale (Birchwood). Univariate and multivariable analyses were used to generate results.Out of 126 subjects, 98 (78%) completed follow-up, of which 70 (71.4%) achieved symptomatic remission within mean duration of 8.05 (4.54) months. Besides, having long DUP and separated/divorced/widowed (adjusted hazard ratio [aHR] = 0.07, 95%CI = [0.01, 0.46]), long DUP and poor insight (aHR = 0.18, 95%CI = [0.04, 0.89]), poor insight and separated/divorced/widowed (aHR = 0.09, 95%CI = [0.01, 0.70]), deteriorating premorbid functioning (aHR = 0.47, 95%CI = [0.23, 0.97]), family history of psychiatric disorders (aHR = 0.52, 95%CI = (0.30, 0.93]), and being male (aHR = 0.47, 95%CI = [0.24, 0.92]) delayed symptomatic remission.These results propose that psychological interventions and social support for mental health problems are warranted and may enhance better response to antipsychotic medications among separated/divorced/widowed patients with long DUP or poor insight, and poor insight patients with long DUP. Deteriorating premorbid functioning, family history of psychiatric disorders and being male continue being important risk factors for poor odds of remission.
尽管未治疗精神病持续时间(DUP)较长与抗精神病药物治疗反应不佳相关,但DUP是否独立影响首发精神病(FEP)症状缓解时间仍不清楚。本研究调查了症状缓解率,并探讨DUP、病前功能、整体功能、自知力和社会人口学特征是否与FEP症状缓解时间独立相关。这项前瞻性研究纳入了2009年6月至2012年9月期间的126例FEP患者(年龄18 - 65岁)。受试者在接受抗精神病药物治疗后进行了18个月的每月随访。阳性和阴性症状的缓解按照精神分裂症缓解工作组(RSWG)标准定义。如果受试者的阴性和阳性症状均缓解,则被定义为“症状缓解”。在基线时,测量了以下解释变量:社会人口学特征;DUP分为短(≤5个月)和长(>5个月);根据Cannon - Spoor病前适应量表,病前功能分为恶化、稳定差和稳定好;根据功能总体评定量表,整体功能分为“最差(1 - 10)至严重(41 - 50)”和“中等(51 - 60)至上等(91 - 100)”;根据自知力量表(Birchwood),自知力分为差(≤8)和好(≥9)。采用单变量和多变量分析得出结果。
126名受试者中,98名(78%)完成了随访,其中70名(71.4%)在平均8.05(4.54)个月内实现了症状缓解。此外,长DUP且分居/离婚/丧偶(调整后风险比[aHR]=0.07,95%置信区间[CI]=[0.01, 0.46])、长DUP且自知力差(aHR = 0.18,95%CI = [0.04, 0.89])、自知力差且分居/离婚/丧偶(aHR = 0.09,95%CI = [0.01, 0.70])、病前功能恶化(aHR = 0.47,95%CI = [0.23, 0.97])、有精神疾病家族史(aHR = 0.52,95%CI = (0.30, 0.93])以及男性(aHR = 0.47,95%CI = [0.24, 0.92])会延迟症状缓解。
这些结果表明,对于有心理健康问题的患者,心理干预和社会支持是必要的,可能会提高DUP长或自知力差的分居/离婚/丧偶患者以及自知力差且DUP长的患者对抗精神病药物的反应。病前功能恶化、有精神疾病家族史和男性仍然是缓解几率低的重要危险因素。